A randomized, double-blind, placebo-controlled, parallel, proof of concept study to evaluate the effectiveness of ramelteon to advance the timing of sleep in individuals with delayed sleep phase syndrome (DSPS).

Trial Profile

A randomized, double-blind, placebo-controlled, parallel, proof of concept study to evaluate the effectiveness of ramelteon to advance the timing of sleep in individuals with delayed sleep phase syndrome (DSPS).

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Circadian rhythm sleep disorders
  • Focus Therapeutic Use
  • Sponsors Takeda Global Research and Development Center
  • Most Recent Events

    • 19 May 2009 Results presented at APA 2009.
    • 20 Dec 2008 Planned number of patients changed from 120 to 132 as reported by ClinicalTrials.gov.
    • 20 Dec 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top